Contacts

Shari Goldfarb, MD

CONTACT

646-888-5080 goldfars@mskcc.org

Jeanne Carter, PhD

CONTACT

646-888-5076 carterj@mskcc.org

Sponsors

Lead Sponsor

Memorial Sloan Kettering Cancer Center

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•≥18 years of age at the time of signing informed consent.
•Stage 0-3 hormone-receptor positive breast cancer confirmed at MSKCC
•Able to complete study questionnaires in English or Spanish
•Breast cancer patients must have completed primary therapy (surgery, and/or chemotherapy, and/or radiation therapy) or currently on maintenance therapy
•Currently on an aromatase inhibitor or tamoxifen or Selective Estrogen Receptor Modulators (SERM)
•Currently have no clinical evidence of disease
•Reporting being bothered by vaginal symptoms of estrogen deprivation (i.e., vaginal dryness, dyspareunia, or discomfort \[pain with intercourse or examination\])
•A total score of 4 or greater in VAS
•Without history of other cancers (excluding non-melanoma skin cancer)
•Must sign an informed consent indicating that the participant understands the purpose of, and procedures required for the study and is willing to participate in the study

Exclusion Criteria

•Inability to provide informed consent
•Vaginal bleeding of unknown etiology within 12 months of study entry
•Currently taking hormone replacement therapy \[local or systemic\] (Patients must discontinue for 4 weeks in order to be eligible prior to study enrollment)
•Existing use of external estrogens or nonhormonal moisturizers (Patients must discontinue for 4 weeks in order to be eligible prior to study enrollment)
•No known allergies to any ingredients in 10mg HLA suppository

Related studies

RECRUITINGPhase 3

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

NCT06500481 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more

RECRUITINGNA

A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship

NCT07655934 · Breast Cancer

RECRUITINGNA

MRg-NIRS Imaging System Breast Cancer Trial

NCT06400563 · Breast Cancer

RECRUITINGPhase 1/2

A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

NCT06188520 · ER+ HER2- Advanced Breast Cancer, High-grade Serous Ovarian Cancer (HGSOC)

RECRUITINGPhase 1/2

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

NCT07288359 · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, and more

View all related studies →

A Study of Revaree Plus in People With Breast Cancer

What this study is about

Save this trial guide to your notes

Contacts

Sponsors

Related studies

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship

MRg-NIRS Imaging System Breast Cancer Trial

A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Trial snapshot

Condition

Locations shown

For caregivers